Abstract:Stimuli-responsive prodrugs are promising candidates for effective cancer therapy, while the linker is one of the indispensable components in prodrugs. However, with so many endogenous stimuli to compete with in the tumor microenvironment (TME) and intertumoral heterogeneity of chemical species, we must mull over the properties of the linker to guarantee efficient drug release. Here, we prepared five kinds of stimuli-responsive doxorubicin (DOX) dimeric prodrug self-assembled nanoparticles (NPs) and compared their antitumor effects against triple-negative breast cancer (TNBC) and hepatocellular carcinoma (HCC) tumors. These prodrugs were linked with stable carbon chain, trace amide disulfide and traceless carbamate disulfide, borate ester, and dimethylmaleamide linkers and could self-assemble into NPs without any carrier. With these self-assembled NPs, we demonstrated that the traceless carbamate disulfide linker exhibited superiority than the noncleavable carbon chain and trace amide disulfide linkers. However, no prodrug NPs exhibited superior antitumor efficacy and cleavage rates in the tumors of TNBC and HCC. We further revealed that different cancer cells exhibited distinctive capacities to maintain endogenous chemical species, while intertumoral heterogeneity hampered the availability of prodrug NPs with broad-spectrum superiority. Our results suggest that a precise and traceless linker should be pursued for the construction of potent prodrugs, providing significant implications for the development of efficient stimuli-responsive prodrugs.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.chemmater.1c03346.Materials and synthetic procedures of DOX dimers; characterization data; HRMS spectra of DOX dimers; size distribution and TEM image of DOX2-SS(SH) NPs; stability of prodrug NPs; DOX release kinetics; HPLC spectra of prodrug NPs; intracellular drug distribution; concentration–response cytotoxicity curves of prodrug NPs; and H&E staining, TUNEL, and ki67 fluorescence staining of tumor sections and their quantification (PDF)This article has not yet been cited by other publications.

The effect of lengths of branched-chain fatty alcohols on the efficacy and safety of docetaxel-prodrug nanoassemblies

Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment

Minor change in the length of carbon chain has a great influence on the antitumor effect of paclitaxel-fatty alcohol prodrug nanoassemblies: Small roles, big impacts

Interactions of Self-Assembled Bletilla S triata Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles.

Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies

Tailoring modification modules of paclitaxel prodrug nanoassemblies to manipulate efficacy and tolerance

Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies

Rational Engineering Docetaxel Prodrug Nanoassemblies: Response Modules Guiding Efficacy Enhancement and Toxicity Reduction

Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities

The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles

Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy

Dual role of triglyceride structures facilitates anti-tumor drug delivery: Both as a self-assembling module and a responsive module

Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles

PDLLA Length on Anti-Breast Cancer Efficacy of Acid-Responsive Self-Assembling Mpeg-Pdlla‒docetaxel Conjugates

Nitric oxide-releasing docetaxel prodrug nanoplatforms for effective cancer therapy

Influence of Linkers within Stimuli-Responsive Prodrugs on Cancer Therapy: A Case of Five Doxorubicin Dimer-Based Nanoparticles

Probing the Impact of Surface Functionalization Module on the Performance of Mitoxantrone Prodrug Nanoassemblies: Improving the Effectiveness and Safety

Complete regression of xenografted breast tumors by dextran-based dual drug conjugates containing paclitaxel and docosahexaenoic acid

Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.